Growth characteristics and pathogenesis of experimental Pneumocystis carinii pneumonia
- PMID: 6966614
- PMCID: PMC550864
- DOI: 10.1128/iai.27.3.928-937.1980
Growth characteristics and pathogenesis of experimental Pneumocystis carinii pneumonia
Abstract
Pneumocystis carinii pneumonia was produced in two groups of rats by the administration of corticosteroids, a low-protein (8%) diet, and tetracycline in the drinking water. A third group not on corticosteroids or a low-protein diet served as controls. Members of the first group were sacrificed weekly for 8 weeks, and lungs were examined. A highly significant correlation was found between the histopathological assessment of the intensity of P. carinii infection and the number of cysts counted in enzyme-digested lungs. P. carinii progressively filled alveoli, and cyst counts increased from less than or equal to 10(4) to 10(9) cysts/g of lung at peak intensity of infection at 7 to 8 weeks. The second group of rats was placed on a regular diet and tapering doses of corticosteroids after week 4, and they were sacrificed at varying intervals for up to 21 weeks. P. carinii was not cleared from the lungs until after week 13 (more than 6 weeks after discontinuation of all steroids). Histologically, there was an increased prominence of alveolar macrophages and the progressive development of interstitial mononuclear cell infiltrate and fibrosis. Thus, P. carinii grows grows slowly in vivo and interacts with specific host cells. The resulting changes may be important in the pathogenesis of the infection and in the clearance of the organism from the lung after immunocompetence has been restored.
Similar articles
-
Interaction of Pneumocystis carinii with host lungs: an ultrastructural study.Infect Immun. 1980 Aug;29(2):692-703. doi: 10.1128/iai.29.2.692-703.1980. Infect Immun. 1980. PMID: 6971258 Free PMC article.
-
Correlation of organism burden and alveolar macrophage counts during infection with Pneumocystis carinii and recovery.Clin Diagn Lab Immunol. 2003 Mar;10(2):293-302. doi: 10.1128/cdli.10.2.293-302.2003. Clin Diagn Lab Immunol. 2003. PMID: 12626457 Free PMC article.
-
Relationship between the burden of Pneumocystis carinii, the inflammatory reaction and lung injury in Pneumocystis carinii pneumonia.Chin Med J (Engl). 2000 Dec;113(12):1071-4. Chin Med J (Engl). 2000. PMID: 11776138
-
Interactions of parasite and host epithelial cell cycle regulation during Pneumocystis carinii pneumonia.J Lab Clin Med. 1997 Aug;130(2):132-8. doi: 10.1016/s0022-2143(97)90089-5. J Lab Clin Med. 1997. PMID: 9280140 Review. No abstract available.
-
[Pneumocystis carinii pneumonia--a review].Immun Infekt. 1986 Sep;14(5):170-7. Immun Infekt. 1986. PMID: 2429914 Review. German.
Cited by
-
Application of DNA amplification to pneumocystosis: presence of serum Pneumocystis carinii DNA during human and experimentally induced Pneumocystis carinii pneumonia.J Exp Med. 1992 Nov 1;176(5):1327-33. doi: 10.1084/jem.176.5.1327. J Exp Med. 1992. PMID: 1402679 Free PMC article.
-
The effect of corticosteroid treatment on the cell surface glycocalyx of the rat pulmonary alveolus: relevance to the host-parasite relationship in pneumocystis carinii infection.Br J Exp Pathol. 1984 Jun;65(3):347-54. Br J Exp Pathol. 1984. PMID: 6204668 Free PMC article.
-
Quantification and assessment of viability of Pneumocystis carinii organisms by flow cytometry.J Clin Microbiol. 1991 May;29(5):911-5. doi: 10.1128/jcm.29.5.911-915.1991. J Clin Microbiol. 1991. PMID: 2056058 Free PMC article.
-
Outbreaks of Pneumocystis carinii pneumonia in colonies of immunodeficient mice.Infect Immun. 1989 Jan;57(1):62-70. doi: 10.1128/iai.57.1.62-70.1989. Infect Immun. 1989. PMID: 2642471 Free PMC article.
-
Method of testing the susceptibility of Pneumocystis carinii to antimicrobial agents in vitro.Antimicrob Agents Chemother. 1985 Dec;28(6):796-801. doi: 10.1128/AAC.28.6.796. Antimicrob Agents Chemother. 1985. PMID: 3936409 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources